Effects on resting cerebral blood flow and functional connectivity induced by metoclopramide: a perfusion MRI study in healthy volunteers

BACKGROUND AND PURPOSE The substituted benzamide, metoclopramide, is a dopamine receptor antagonist and is widely prescribed in the symptomatic treatment of nausea and vomiting, although it can cause adverse motor and non‐motor side effects. The effects of metoclopramide on brain metabolism have not been investigated to date.

[1]  Jeff H. Duyn,et al.  Mapping resting-state functional connectivity using perfusion MRI , 2008, NeuroImage.

[2]  M. Raichle.  Behind the scenes of functional brain imaging: a historical and physiological perspective. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Daniel Weintraub,et al.  Recognition and Treatment of Depression in Parkinson's Disease , 2003, Journal of geriatric psychiatry and neurology.

[4]  T. Feltes,et al.  The Effects of Dopamine Infusion on Regional Blood Flow in Newborn Lambs , 1987, Pediatric Research.

[5]  A. Egerton,et al.  Modelling prefrontal cortex deficits in schizophrenia: implications for treatment , 2008, British journal of pharmacology.

[6]  G. Glover,et al.  Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control , 2007, The Journal of Neuroscience.

[7]  Feng Xu,et al.  Estimation of labeling efficiency in pseudocontinuous arterial spin labeling , 2010, Magnetic resonance in medicine.

[8]  D. S. Williams,et al.  Magnetic resonance imaging of perfusion using spin inversion of arterial water. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D R Medoff,et al.  Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. , 1996, The American journal of psychiatry.

[10]  Eric C Wong,et al.  Vessel‐encoded arterial spin‐labeling using pseudocontinuous tagging , 2007, Magnetic resonance in medicine.

[11]  Donald S. Williams,et al.  Perfusion imaging , 1992, Magnetic resonance in medicine.

[12]  A. Craig,et al.  How do you feel — now? The anterior insula and human awareness , 2009, Nature Reviews Neuroscience.

[13]  P. Goldman-Rakic,et al.  The anatomy of dopamine in monkey and human prefrontal cortex. , 1992, Journal of neural transmission. Supplementum.

[14]  Hengyi Rao,et al.  Arterial spin-labeled perfusion MRI in basic and clinical neuroscience , 2009, Current opinion in neurology.

[15]  Guide to Receptors and Channels (GRAC), 4th edition , 2009, British journal of pharmacology.

[16]  Maurizio Corbetta,et al.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Sedvall,et al.  Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.

[18]  A. Crane,et al.  Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  J S Fowler,et al.  Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. , 1994, The American journal of psychiatry.

[20]  D. Alsop,et al.  Continuous flow‐driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields , 2008, Magnetic resonance in medicine.

[21]  Carol A. Tamminga,et al.  Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia , 2005, Psychiatry Research: Neuroimaging.

[22]  Thomas E. Nichols,et al.  Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate , 2002, NeuroImage.

[23]  Carol A Tamminga,et al.  Functional effects of antipsychotic drugs: comparing clozapine with haloperidol , 2003, Biological Psychiatry.

[24]  J. Detre,et al.  A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling , 2007, Magnetic resonance in medicine.

[25]  J. Jankovic,et al.  Drug Insight: from disturbed motility to disordered movement—a review of the clinical benefits and medicolegal risks of metoclopramide , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[26]  Stephen D. Mayhew,et al.  Remifentanil-induced cerebral blood flow effects in normal humans: dose and ApoE genotype. , 2007, Anesthesia and analgesia.

[27]  P. Seeman.  All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors , 2011, CNS neuroscience & therapeutics.

[28]  W. Weddington,et al.  Organic affective syndrome associated with metoclopramide: case report. , 1986, The Journal of clinical psychiatry.

[29]  M. Nagai,et al.  Insular cortex and neuropsychiatric disorders: A review of recent literature , 2007, European Psychiatry.

[30]  H. Pieniaszek,et al.  Pharmacokinetic comparison of orally‐disintegrating metoclopramide with conventional metoclopramide tablet formulation in healthy volunteers , 2009, Alimentary pharmacology & therapeutics.

[31]  T. MacDonald.  Metoclopramide, domperidone and dopamine in man: actions and interactions , 1991, European Journal of Clinical Pharmacology.

[32]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[33]  P. Beart,et al.  Labelling of high (D-2 receptor) and low affinity sites by [3H]domperidone in homogenates of the corpus striatum of the rat , 1982, Neuroscience Letters.

[34]  David Eidelberg,et al.  Assessment of the progression of Parkinson's disease: a metabolic network approach , 2007, The Lancet Neurology.

[35]  C. Putman,et al.  Flow–area relationship in internal carotid and vertebral arteries , 2008, Physiological measurement.

[36]  S. Kapur,et al.  The "delayed onset" of antipsychotic action--an idea whose time has come and gone. , 2006, Journal of psychiatry & neuroscience : JPN.

[37]  G. Levi,et al.  Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms , 1985, Brain Research.

[38]  John F. Marshall,et al.  Plasticity of [14C]2-deoxy-d-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement , 1980, Brain Research.

[39]  A. Steiger,et al.  Persistent generalized anxiety after brief exposure to the dopamine antagonist metoclopramide , 2007, Psychiatry and clinical neurosciences.

[40]  T. Anfinson.  Akathisia, panic, agoraphobia, and major depression following brief exposure to metoclopramide. , 2002, Psychopharmacology bulletin.

[41]  David C. Alsop,et al.  Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: A non-invasive MRI pilot study , 2008, NeuroImage.

[42]  M. Martres,et al.  Localisation and pharmacological characterisation of D-2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I]iodosulpride. , 1985, European journal of pharmacology.

[43]  J. R. Augustine.  Circuitry and functional aspects of the insular lobe in primates including humans , 1996, Brain Research Reviews.

[44]  D. Alsop,et al.  Parkinson's Disease Spatial Covariance Pattern: Noninvasive Quantification with Perfusion MRI , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  T. Jung,et al.  Regional CBF changes in Parkinson’s disease: a correlation with motor dysfunction , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[46]  Simon B. Eickhoff,et al.  A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data , 2005, NeuroImage.

[47]  John C Gore,et al.  Assessing functional connectivity in the human brain by fMRI. , 2007, Magnetic resonance imaging.

[48]  John A Detre,et al.  Precision of the CASL‐perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories , 2003, Journal of magnetic resonance imaging : JMRI.

[49]  R. M. Shearer,et al.  Tardive akathisia and agitated depression during metoclopramide therapy , 1984, Acta psychiatrica Scandinavica.

[50]  P. Goldman-Rakic,et al.  Distribution of dopaminergic receptors in the primate cerebral cortex: Quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390 , 1991, Neuroscience.

[51]  W. Gibb,et al.  Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[52]  H. Kita,et al.  Origins of GABAA and GABAB Receptor-Mediated Responses of Globus Pallidus Induced after Stimulation of the Putamen in the Monkey , 2006, The Journal of Neuroscience.

[53]  David Eidelberg,et al.  An Examination of Executive Dysfunction Associated with Frontostriatal Circuitry in Parkinson's Disease , 2006, Journal of clinical and experimental neuropsychology.

[54]  P. Gaspar,et al.  D1 and D2 Receptor Gene Expression in the Rat Frontal Cortex: Cellular Localization in Different Classes of Efferent Neurons , 1995, The European journal of neuroscience.

[55]  R. Buxton,et al.  Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II) , 1998 .

[56]  D. Hoyer.  Serotonin 5-HT3, 5-HT4, and 5-HT-M receptors. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[57]  J. Doyon,et al.  Distinct basal ganglia territories are engaged in early and advanced motor sequence learning. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Buxton,et al.  A Model for the Coupling between Cerebral Blood Flow and Oxygen Metabolism during Neural Stimulation , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[59]  J. Detre,et al.  Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: feasibility study. , 2005, Radiology.

[60]  Y. Itoyama,et al.  Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease , 2001, Journal of the Neurological Sciences.

[61]  M. Schnall,et al.  Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla , 2002, Magnetic resonance in medicine.

[62]  Jeff Duyn,et al.  H215O PET validation of steady‐state arterial spin tagging cerebral blood flow measurements in humans , 2000, Magnetic resonance in medicine.

[63]  G. Mengod,et al.  D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment , 2010, Neuroscience.

[64]  Daniel Gallichan,et al.  Measuring the Effects of Remifentanil on Cerebral Blood Flow and Arterial Arrival Time Using 3D Grase MRI with Pulsed Arterial Spin Labelling , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[65]  J. Rotrosen,et al.  Metoclopramide: Antipsychotic efficacy of a drug lacking potency in receptor models , 2004, Psychopharmacology.

[66]  N. Hurtado,et al.  The effect of intravenous metoclopramide on blood pressure in normotensive and hypertensive subjects. , 1996, International journal of clinical pharmacology and therapeutics.

[67]  M. Monshouwer,et al.  Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid , 2009, Drug Metabolism and Disposition.

[68]  Thomas E. Nichols,et al.  Nonstationary cluster-size inference with random field and permutation methods , 2004, NeuroImage.

[69]  S. Stone-Elander,et al.  Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography , 2004, Psychopharmacology.

[70]  N. Yoshida,et al.  Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum. , 1998, Japanese journal of pharmacology.

[71]  P. Stanzione,et al.  Perfusion-weighted dynamic susceptibility (DSC) MRI: basal ganglia hemodynamic changes after apomorphine in Parkinson's disease , 2002, Neurological Sciences.